Other languages Johnson & Johnson Borsa Italiana

Equities

Real-time Estimate Tradegate Other stock markets 06:55:55 2024-06-14 am EDT			5-day change	1st Jan Change
135.9 ^EUR	+0.77%		+0.10%	-4.10%

Jun. 13	High-risk health workers can get routine Ebola vaccine, Gavi says	RE
Jun. 13	Xencor to Regain Exclusive Global Rights to CD20 x CD3 Bispecific T-Cell Engager	MT

High-risk health workers can get routine Ebola vaccine, Gavi says	Jun. 13
High-risk health workers can get routine Ebola vaccine, says Gavi	Jun. 13
Cancer victims ask court to block J&J talc bankruptcy	Jun. 12
Sector Update: Health Care Stocks Softer Late Afternoon	Jun. 11
Sector Update: Health Care	Jun. 11
Johnson & Johnson to Pay $700 Million in Talc Case Settlement With 43 State Prosecutors	Jun. 11
RTW Biotech portfolio company to sell subsidiary for USD1.25 billion	Jun. 11
Top law firms in US opioid lawsuits to get hundreds of millions in fees	Jun. 07
J&J-backed Rapport Therapeutics shares debut nearly 6% higher	Jun. 07
J&J : la FDA approuve VELYS dans l'arthroplastie du genou	Jun. 07
AbbVie's tight grip on Humira market raises concerns about biosimilars	Jun. 07
J&J-backed Rapport Therapeutics raises $136 mln in US IPO	Jun. 06
Borsa di Italia: Verso l'infinito e oltre	Jun. 06
Bolsa de Madrid: Hasta el infinito y más allá	Jun. 06
J&J : sollicite la FDA une indiation élargie du Prezcobix	Jun. 05
J&J : essai concluant pour Carvykti dans le myélome multiple	Jun. 04
J&J : essai prometteur pour Tecvayli dans le myélome multiple	Jun. 04
Johnson & Johnson Ordered to Pay $260 Million In Talc Powder Case	Jun. 04
Borsa di Italia: Mai contenti!	Jun. 04
J&J must pay $260 million in latest talc trial, Oregon jury says	Jun. 03

No results for this search

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm EST